Noninvasive assessment of characteristics of novel anti-HER2

Persistent Degradation of HER2 Protein by Hybrid nanoPROTAC for Programmed Cell Death

Cancers, Free Full-Text

Non-invasive assessment for intratumoural distribution of interstitial fluid flow - ScienceDirect

Expression of anti-HER2 scFv by SHuffle® strains containing pET-22

The landscape of d16HER2 splice variant expression across HER2-positive cancers

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer - eBioMedicine

HER2-Low Breast Cancer Can Be Visualized by HER2 PET

Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model

Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications - ScienceDirect

Cancers, Free Full-Text

Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer

Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer - ScienceDirect

Flow Chart of study. Download Scientific Diagram

Frontiers Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission

IJMS, Free Full-Text